Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hemp Oil for Androgenetic Alopecia
NCT04842383Phase 1Unknown
- Start
- Apr 2021
- Primary completion
- Oct 2021
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial in androgenetic alopecia (AGA). Primary endpoint: Change in nonvellus hair count in 1cm2 area of the bald scalp at 6 months. Status: unknown.
02
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on NCT04842383.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04842383.